🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 7 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/06/1994 | 43,04 | 45,85 | 43,04 | 45,85 | +6,52% | 6,52% | 802 |
| 01/06/1994 | 43,04 | 43,04 | 43,04 | 43,04 | +0,00% | 0,00% | 0 |
| 31/05/1994 | 43,04 | 43,04 | 43,04 | 43,04 | -6,12% | 0,00% | 668 |
| 27/05/1994 | 45,85 | 45,85 | 44,45 | 45,85 | +6,52% | 3,06% | 2.164 |
| 26/05/1994 | 43,98 | 43,98 | 43,04 | 43,04 | -6,12% | 2,13% | 347 |
| 25/05/1994 | 45,85 | 48,66 | 43,04 | 45,85 | -0,51% | 12,24% | 6.412 |
| 24/05/1994 | 46,32 | 46,79 | 46,09 | 46,09 | -1,50% | 1,52% | 7.000 |
| 23/05/1994 | 46,79 | 46,79 | 46,79 | 46,79 | +0,00% | 0,00% | 0 |
| 20/05/1994 | 48,66 | 48,66 | 46,79 | 46,79 | -3,85% | 3,85% | 374 |
| 19/05/1994 | 46,79 | 48,66 | 46,79 | 48,66 | +0,00% | 4,00% | 4.969 |
| 18/05/1994 | 48,66 | 48,66 | 48,19 | 48,66 | +0,00% | 0,96% | 214 |
| 17/05/1994 | 46,79 | 48,66 | 46,79 | 48,66 | +0,48% | 4,00% | 4.221 |
| 16/05/1994 | 48,66 | 48,66 | 48,42 | 48,42 | +0,00% | 0,48% | 1.069 |
| 13/05/1994 | 48,66 | 48,66 | 48,42 | 48,42 | +1,47% | 0,48% | 855 |
| 12/05/1994 | 47,72 | 47,72 | 47,72 | 47,72 | +0,99% | 0,00% | 1.069 |
| 11/05/1994 | 46,79 | 47,26 | 46,79 | 47,26 | -2,88% | 1,00% | 3.019 |
| 10/05/1994 | 50,53 | 50,53 | 48,66 | 48,66 | -3,70% | 3,70% | 107 |
| 09/05/1994 | 46,79 | 50,53 | 46,79 | 50,53 | +8,00% | 8,00% | 374 |
| 06/05/1994 | 46,79 | 50,53 | 46,79 | 46,79 | -7,41% | 8,00% | 267 |
| 05/05/1994 | 46,79 | 50,53 | 46,79 | 50,53 | +8,00% | 8,00% | 3.714 |
| 04/05/1994 | 43,98 | 46,79 | 43,98 | 46,79 | +6,38% | 6,38% | 7.187 |
| 03/05/1994 | 43,98 | 43,98 | 43,98 | 43,98 | +6,82% | 0,00% | 2.271 |
| 02/05/1994 | 44,92 | 44,92 | 41,17 | 41,17 | -10,20% | 8,33% | 4.168 |
| 29/04/1994 | 45,85 | 45,85 | 42,11 | 45,85 | +0,00% | 8,16% | 347 |
| 28/04/1994 | 45,85 | 45,85 | 42,11 | 45,85 | +0,00% | 8,16% | 401 |
| 26/04/1994 | 43,98 | 45,85 | 43,04 | 45,85 | +4,26% | 6,38% | 588 |
| 25/04/1994 | 45,85 | 45,85 | 43,98 | 43,98 | +2,17% | 4,08% | 4.729 |
| 22/04/1994 | 43,04 | 43,04 | 43,04 | 43,04 | -6,12% | 0,00% | 53 |
| 21/04/1994 | 45,85 | 45,85 | 45,85 | 45,85 | +2,08% | 0,00% | 53 |
| 20/04/1994 | 44,92 | 45,85 | 43,04 | 44,92 | -4,00% | 6,25% | 16.751 |